Internal conflicts over whether — and when — to approve boosters are part of a tumultuous season with few parallels for the federal agency.
At the besieged FDA, ‘it never stops!’ as decisions loom on boosters, pediatric shots and more
Internal conflicts over whether — and when — to approve boosters are part of a tumultuous season with few parallels for the federal agency.